Monitoring phospholipids for assessment of ion enhancement and ion suppression in ESI and APCI LC/MS/MS for chlorpheniramine in human plasma and the importance of multiple source matrix effect evaluations.

Monitoring phospholipids for assessment of ion enhancement and ion suppression in ESI and APCI LC/MS/MS for chlorpheniramine in human plasma and the importance of multiple source matrix effect evaluations.

Item

http://www.wikidata.org/entity/Q33441101

Q33441101

about

Using Visualized Matrix Effects to Develop and Improve LC-MS/MS Bioanalytical Methods, Taking TRAM-34 as an Example Laser-induced acoustic desorption/atmospheric pressure chemical ionization mass spectrometry An overview of matrix effects in liquid chromatography-mass spectrometry.HPLC/APCI mass spectrometry of saturated and unsaturated hydrocarbons by using hydrocarbon solvents as the APCI reagent and HPLC mobile phase.Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry Comparison of electrospray ionization and atmospheric chemical ionization coupled with the liquid chromatography-tandem mass spectrometry for the analysis of cholesteryl esters.Impact of APCI ionization source in liquid chromatography tandem mass spectrometry based tissue distribution studies.Turbulent flow chromatography in bioanalysis: a review.Steroid assays in paediatric endocrinology.Simultaneous quantitative analysis of dextromethorphan, dextrorphan and chlorphenamine in human plasma by liquid chromatography-electrospray tandem mass spectrometry.The impact of phospholipids and phospholipid removal on bioanalytical method performance.Bioanalysis of antihistamines for clinical or forensic purposes.Comparison of blood plasma sample preparation methods for combined LC-MS lipidomics and metabolomics Selected reaction monitoring applied to proteomics.A systematic approach for developing a robust LC-MS/MS method for bioanalysis.Dimer ion formation and intermolecular fragmentation of 1,2-diacylglycerols revealed by electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry for more comprehensive lipid analysis.Simultaneous Determination and Quantitation of Paraquat, Diquat, Glufosinate and Glyphosate in Postmortem Blood and Urine by LC-MS-MS.Matrix effect management in liquid chromatography mass spectrometry: the internal standard normalized matrix effect.Lipid specific molecular ion emission as a function of the primary ion characteristics in TOF-SIMS.Selection of a representative matrix for the multiresidue analysis of nine β-agonists in animal tissues and urine with LC-MS/MS.Evaluation and subsequent minimization of matrix effects caused by phospholipids in LC-MS analysis of biological samples.Capillary electrophoresis coupled to electrospray mass spectrometry through a coaxial sheath flow interface and semi-permanent phospholipid coating for the determination of oligosaccharides labeled with 1-aminopyrene-3,6,8-trisulfonic acid.Solid-phase extraction based on hydrophilic interaction liquid chromatography with acetone as eluent for eliminating matrix effects in the analysis of biological fluids by LC-MS.Simultaneous determination of metolazone and valsartan in plasma by on-line SPE coupled with liquid chromatography/tandem mass spectrometry.Extraction methods for the removal of phospholipids and other endogenous material from a biological fluid.MATRIX EFFECTS IN LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY Computational Design of a Selective Molecular Imprinted Polymer for Extraction of Pseudoephedrine from Plasma and Determination by HPLC

P2860

Q28546704-8EF52969-049E-4E46-A6C1-09B8A2A5F210 Q30475888-F5ECC315-9A84-4266-98F6-D298BB28B7C8 Q33450184-1413CEAA-D9CC-4633-8B0C-EFEEE3DEEF1A Q33453687-CFECE50B-D85B-4806-A4FD-C0B6A76B71E4 Q33463058-98E14C54-D4D4-4305-9882-61F14D6EFE30 Q33464797-E46B69E9-D2D6-4A27-B360-892285E22083 Q33467689-21573B37-16F4-4595-82A3-18C65B0175DA Q34317104-0055DF21-1298-412A-8454-30FBECBA9256 Q34423161-AFC4360F-9B4E-4D83-BA16-88F835EE9A12 Q35047317-C32CCD36-2502-4B14-8699-E0C9721DA4B7 Q35895799-07AB924C-E89B-46E2-BF1E-1518FFDEBE81 Q35977473-4C8AA8F3-22FF-4001-B8A9-292C6FBBA5DD Q36090471-0242770B-AE14-4C1B-87BB-35D531AF17C6 Q37851918-0B93A7A9-2670-4297-B299-9D73131BF0D0 Q38068911-DABA2DF0-9835-4FD5-81D1-2F331B302A86 Q39168064-567246C3-1F97-4E72-9F12-3EC9112BD16C Q39658599-E528BC06-51BF-4F63-9EC8-8D3D17F98570 Q40122652-4A9AA92A-7CF6-42C8-8055-8AD305B610C5 Q40959578-156D0C34-2E22-4335-A273-4A2260240CE3 Q44097462-FB8EE807-9E2E-47CC-8B2B-C548A8C56BAD Q44329186-84410D7F-3336-44AA-8EC1-3BC9BA061287 Q44974270-D7991CF8-2A50-4328-B10D-2AFF3A079EEA Q46220965-8B9E18AF-495C-483E-A91B-5F9A84A1D88C Q47845332-240D9608-B8DC-4C55-9A43-E9BC81461E55 Q53394049-19EDFA99-BA3A-4A20-B822-A326F458F117 Q56035257-BC5C34C2-D34D-47E8-99C8-3C1A5ED4954B Q58251956-D429AFB2-7103-4549-93EE-988675CFD27A

P2860

Monitoring phospholipids for assessment of ion enhancement and ion suppression in ESI and APCI LC/MS/MS for chlorpheniramine in human plasma and the importance of multiple source matrix effect evaluations.

Item

http://www.wikidata.org/entity/Q33441101

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu